Kontafarma China Holdings Limited

SEHK:1312 Stock Report

Market Cap: HK$190.0m

Kontafarma China Holdings Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Feifei Wang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

May 31
Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

Recent updates

Kontafarma China Holdings Limited's (HKG:1312) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Oct 09
Kontafarma China Holdings Limited's (HKG:1312) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Is Kontafarma China Holdings (HKG:1312) Weighed On By Its Debt Load?

Sep 04
Is Kontafarma China Holdings (HKG:1312) Weighed On By Its Debt Load?

Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

May 31
Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

There's No Escaping Kontafarma China Holdings Limited's (HKG:1312) Muted Revenues Despite A 61% Share Price Rise

May 24
There's No Escaping Kontafarma China Holdings Limited's (HKG:1312) Muted Revenues Despite A 61% Share Price Rise

Health Check: How Prudently Does Kontafarma China Holdings (HKG:1312) Use Debt?

Dec 28
Health Check: How Prudently Does Kontafarma China Holdings (HKG:1312) Use Debt?

Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Sep 01
Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Dec 29
Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Health Check: How Prudently Does Tongfang Kontafarma Holdings (HKG:1312) Use Debt?

Sep 15
Health Check: How Prudently Does Tongfang Kontafarma Holdings (HKG:1312) Use Debt?

Tongfang Kontafarma Holdings (HKG:1312) Has Debt But No Earnings; Should You Worry?

Apr 20
Tongfang Kontafarma Holdings (HKG:1312) Has Debt But No Earnings; Should You Worry?

Is Tongfang Kontafarma Holdings (HKG:1312) A Risky Investment?

Nov 04
Is Tongfang Kontafarma Holdings (HKG:1312) A Risky Investment?

Tongfang Kontafarma Holdings' (HKG:1312) Shareholders Are Down 90% On Their Shares

Feb 18
Tongfang Kontafarma Holdings' (HKG:1312) Shareholders Are Down 90% On Their Shares

These 4 Measures Indicate That Tongfang Kontafarma Holdings (HKG:1312) Is Using Debt Extensively

Dec 07
These 4 Measures Indicate That Tongfang Kontafarma Holdings (HKG:1312) Is Using Debt Extensively

CEO

Feifei Wang

less than a year

Tenure

Mr. Feifei Wang is Executive Chairman & President of Kontafarma China Holdings Limited from June 7, 2024.


Leadership Team

NamePositionTenureCompensationOwnership
Feifei Wang
Executive Chairman & Presidentless than a yearno datano data
Zixiu Guo
Financial Controller & Executive Directorless than a yearno datano data
Jie Zhang
Chief Operating Officer4.2yrsno datano data
Linna Qiao
VP & Executive Directorless than a yearno datano data
Jiankun Liu
Executive Directorless than a yearno datano data
Lok Tung Chan
Company Secretaryless than a yearno datano data

0.4yrs

Average Tenure

Experienced Management: 1312's management team is not considered experienced ( 0.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Feifei Wang
Executive Chairman & Presidentless than a yearno datano data
Zixiu Guo
Financial Controller & Executive Directorless than a yearno datano data
Linna Qiao
VP & Executive Directorless than a yearno datano data
Jiankun Liu
Executive Directorless than a yearno datano data
Lai Wah Tang
Independent Non-Executive Directorless than a yearno datano data
Yu Huang
Non-Executive Director10.7yrsHK$1.67mno data
Ho Ming Ho
Independent Non-Executive Directorless than a yearno datano data
Xiaomin Yao
Independent Non-Executive Directorless than a yearno datano data

0.4yrs

Average Tenure

57.5yo

Average Age

Experienced Board: 1312's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.